In section Market Quotes

Artivion Shares Slide as Earnings Miss Offsets Return to Profit

Artivion shares tumbled Friday after the cardiac and vascular surgery specialist reported fourth-quarter adjusted earnings and revenue that fell just short of analyst expectations, overshadowing the company’s successful swing to a net profit.

Artivion Shares Slide as Earnings Miss Offsets Return to Profit

The stock dropped 10% to $36.43 during Friday trading, a sharp reversal for a company that has otherwise seen its valuation climb 21% over the past year. While the company reported a net profit of $2.4 million, or 5 cents per share—a significant improvement over the $16.5 million loss recorded in the same period last year—investors focused on the narrow miss against Wall Street's performance benchmarks.

On an adjusted basis, Artivion delivered earnings of 17 cents per share. This figure trailed the 18 cents per share anticipated by analysts surveyed by FactSet. Revenue also showed strong year-over-year growth, rising to $116 million from $97.3 million, but ultimately failed to reach the $116.5 million consensus forecast.

Growth Projections for 2024

Despite the immediate market sell-off, Artivion issued an optimistic outlook for the upcoming fiscal year. Management projects full-year revenue to land between $486 million and $504 million, representing a growth rate of 10% to 14%. The company also expects adjusted EBITDA to climb between 18% and 22%, forecasting a range of $105 million to $110 million for the current year, according to the company's financial guidance.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!